Decision Process for Distribution of Funds Received from the CRCEF
The decision process for distribution of funds received by uOttawa to each affiliated institution was described in a signed agreement with each institution. Specifically, the portion of the CRCEF grant attributable to research activities conducted by the affiliated institution’s researchers was determined by the University, based on a dataset and allocation formula with the same methodology used by the CRCEF.
For Stage 1, funding was distributed to each affiliated institution according to the proportion of non-governmental (federal, provincial and municipal) research income generated by that affiliated institution (e.g., the financial data [PDF, 221 KB] reported to the Canadian Association of University Business Officers). See details regarding uOttawa internal allocation in the Equity Diversity and Inclusion (EDI) Strategy below.
The University of Ottawa requested no funds in Stage 2.
For Stage 3, the CRCEF administration will continue with the processes established in Stage1 (see safeguards in the EDI strategy below), with oversight from the uOttawa EDI decision-making committee.
In accordance with program requirements, uOttawa established a transparent and open process, and communicated it widely to the research community, both on a public website and through emails to the research community. On Tuesday September 29, the Office of the Vice-President Research sent an email to the uOttawa research community to describe Stage 3 eligible costs, and the application process with a timeline. An application template was developed to help researchers identify extraordinary direct research costs related to COVID-19, provide justifications for the extraordinary expense, explain how COVID-19 impacted their research, and identify special circumstances which should be considered in deciding the attribution of funds. We held two virtual webinars with researchers who have questions about CRCEF Stage 3 funds. In addition, we worked with the faculties to encourage researchers to submit applications. Researchers were invited to contact central administration staff if they have questions about the program requirements or if they wanted to discuss specific cases or circumstances related to the pandemic or not.
For Stage 3, uOttawa Internal Assessment Criteria are as follow.
Preference will be given to individuals, whose:
1. expenses claimed were not covered by CRCEF Stage 1, COVID-19 research support from the federal research funding agencies, Canada Foundation for Innovation, and other broad-based federal COVID-19 measures (e.g., the Canada Emergency Wage Subsidy).
2. research activities were negatively impacted by COVID-19.
Stage 3 notional budgets were distributed to each affiliated institution according to the proportion of total sponsored research income generated by that affiliated institution (e.g., the financial data [PDF, 221 KB] reported to the Canadian Association of University Business Officers). On September 16, 2020, the affiliated institutions received an updated email regarding the new CRCEF guidelines for Stage 3 and associated webinars. Each Institute developed their own application process making sure that all eligible costs were considered, ensuring support for research that is non-traditional or unconventional, based in indigenous ways of knowing, outside the mainstream of the discipline or focused on gender, race or minority status.
The allocation of funds was as follows:
Institution | Stage 1 Allocation amount | Stage 2 Allocation amount | Stage 3 Allocation amount |
---|
University of Ottawa | $3,467,132.77 | N/A | $2,690,430.33 |
Bruyère Research Institute | $238,251.74 | N/A | $111,120.25 |
Children's Hospital of Eastern Ontario Research Institute | $861,406.26 | N/A | $315,740.93 |
Ottawa Heart Institute Research Corporation | $2,245,588.25 | N/A | $610,415.08 |
Institute of Mental Health Research | $208,607.30 | N/A | $49,680.07 |
Institut du Savoir Montfort | $146,033.63 | N/A | $36,064.41 |
Ottawa Hospital Research Institute | $5,467,373.05 | N/A | $1,688,104.93 |
Total | $12,634,393 | N/A | $5,501,556 |